Trial intelligence / Profile preview

EPI-DILUTE: Epinephrine Concentration in Gastric ESD

NCT07920068Recruiting

Sponsor
Unidade Local de Saúde do Alto Ave
Start
Jul 2025
Primary completion
Feb 2027
Countries
1
01

Overview

Randomised trial of epinephrine in gastric cancer (GC) and gastric dysplasia (2 arms), sponsored by Unidade Local de Saúde do Alto Ave. Primary endpoint: Gastric ESD procedure time. Started Jul 2025; status: recruiting.

02

Drugs

epinephrine
03

Conditions

gastric cancer (GC)gastric dysplasia

Beyond the preview

Go deeper on NCT07920068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07920068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call